Home » Beiträge » 10699

View Beitrag #10699

ID	10699
Ident	Apofrage des Tages 11.04.2024
Titel	Apofrage des Tages 11.04.2024
Balkentitel	APOFRAGE DES TAGES
Created	2024-04-15 15:55:44
Veraltet	0
typ_id	Universal 2023
sub_typ_id	Abgaberätsel
html	<table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px;border-width:0" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-width:0;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="right" style="padding:0;Margin:0;padding-bottom:5px;padding-top:5px;padding-right:0;padding-left:20px;background-color: #e0e0e0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#777777;font-size:12px !important;"><span style="background:transparent">Anzeige</span></p> </td> </tr> <tr> <td align="left" style="padding:0;Margin:0;font-size:0"> <img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/2023q3/newsletter_2023-08-19_g2.jpg" alt="Apofrage des Tages" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title=""> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h3 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:14px;font-style:normal;font-weight:bold;line-height:18px;color:#555555">APOFRAGE DES TAGES</h3> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:0px"> <h2 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:20px;font-style:normal;font-weight:bold;line-height:24px;color:#005CA9">Welche Aussage zu Everolimus Ascend stimmt nicht?</h2> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px !important;letter-spacing:0;color:#555555;font-size:14px">Everolimus Ascend gehört zur Gruppe der Immunsuppressiva. Der Wirkstoff Everolimus greift in den Zellzyklus von T-Lymphozyten ein, indem der Übergang in die Synthese-Phase verhindert wird. In Kombination mit anderen Arzneimitteln wird es zur Vorbeugung der Transplantatabstoßung nach Nieren-, Herz- und Lebertransplantationen eingesetzt.</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px !important;letter-spacing:0;color:#555555;font-size:14px"> Bei richtiger Antwort werden Ihnen 5 DAPs-Punkte gutgeschrieben.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" style="Margin:0;padding-right:20px;padding-left:20px;padding-bottom:20px;padding-top:20px;background-color:#ffffff"> <table cellpadding="0" cellspacing="0" class="es-left" align="left" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:left"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:300px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#005CA9"> <a href="https://www.deutschesapothekenportal.de/wissen/apofrage-des-tages/" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #ffffff; text-decoration: none;background-color: #005CA9; padding: 10px 20px; border: 1px solid #005CA9; display: block;">Zur Apofrage des Tages</a> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <table cellpadding="0" cellspacing="0" class="es-right" align="right" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:right"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:300px" class="pt-20"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#eeeeee"><a href="https://www.meindap.de/apofrage_2024-04-11_ascend-everolimus-produktsteckbrief" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #000; text-decoration: none;background-color: #eeeeee; padding: 10px 20px; border: 1px solid #eeeeee; display: block;">Zum Produktsteckbrief (PDF)</a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0;padding-left:20px;padding-right:20px; font-size:0"> <table border="0" width="100%" height="100%" cellpadding="0" cellspacing="0" class="es-spacer" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td style="padding:0;Margin:0;border-bottom:1px solid #b0b0b0;background:none;height:1px;width:100%;margin:0"></td> </tr> </tbody> </table> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:10px;padding-left:20px;padding-top:10px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">» <a href="https://www.meindap.de/apofrage_2024-04-11_ascend-everolimus-pt" style="mso-line-height-rule:exactly;text-decoration:none;font-size:12px;color:#005CA9" target="_blank">Zum Pflichttext (PDF)</a></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:10px;padding-left:20px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">Bildquelle: © DAP</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
Typo3Html	<table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px;border-width:0" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-width:0;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="right" style="padding:0;Margin:0;padding-bottom:5px;padding-top:5px;padding-right:0;padding-left:20px;background-color: #e0e0e0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#777777;font-size:12px !important;"><span style="background:transparent">Anzeige</span></p> </td> </tr> <tr> <td align="left" style="padding:0;Margin:0;font-size:0"> <img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/2023q3/newsletter_2023-08-19_g2.jpg" alt="Apofrage des Tages" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title=""> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h3 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:14px;font-style:normal;font-weight:bold;line-height:18px;color:#555555">APOFRAGE DES TAGES</h3> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:0px"> <h2 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:20px;font-style:normal;font-weight:bold;line-height:24px;color:#005CA9">Welche Aussage zu Everolimus Ascend stimmt nicht?</h2> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px !important;letter-spacing:0;color:#555555;font-size:14px">Everolimus Ascend gehört zur Gruppe der Immunsuppressiva. Der Wirkstoff Everolimus greift in den Zellzyklus von T-Lymphozyten ein, indem der Übergang in die Synthese-Phase verhindert wird. In Kombination mit anderen Arzneimitteln wird es zur Vorbeugung der Transplantatabstoßung nach Nieren-, Herz- und Lebertransplantationen eingesetzt.</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px !important;letter-spacing:0;color:#555555;font-size:14px"> Bei richtiger Antwort werden Ihnen 5 DAPs-Punkte gutgeschrieben.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" style="Margin:0;padding-right:20px;padding-left:20px;padding-bottom:20px;padding-top:20px;background-color:#ffffff"> <table cellpadding="0" cellspacing="0" class="es-left" align="left" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:left"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:300px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#005CA9"> <a href="https://www.deutschesapothekenportal.de/wissen/apofrage-des-tages/" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #ffffff; text-decoration: none;background-color: #005CA9; padding: 10px 20px; border: 1px solid #005CA9; display: block;">Zur Apofrage des Tages</a> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <table cellpadding="0" cellspacing="0" class="es-right" align="right" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:right"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:300px" class="pt-20"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#eeeeee"><a href="https://www.meindap.de/apofrage_2024-04-11_ascend-everolimus-produktsteckbrief" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #000; text-decoration: none;background-color: #eeeeee; padding: 10px 20px; border: 1px solid #eeeeee; display: block;">Zum Produktsteckbrief (PDF)</a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0;padding-left:20px;padding-right:20px; font-size:0"> <table border="0" width="100%" height="100%" cellpadding="0" cellspacing="0" class="es-spacer" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td style="padding:0;Margin:0;border-bottom:1px solid #b0b0b0;background:none;height:1px;width:100%;margin:0"></td> </tr> </tbody> </table> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:10px;padding-left:20px;padding-top:10px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">» <a href="https://www.meindap.de/apofrage_2024-04-11_ascend-everolimus-pt" style="mso-line-height-rule:exactly;text-decoration:none;font-size:12px;color:#005CA9" target="_blank">Zum Pflichttext (PDF)</a></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:10px;padding-left:20px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">Bildquelle: © DAP</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>

Newsletter 2023

2024-04-11

Beitrag per e-mail verschicken

Auswertungsvorlage anzeigen

Statistik anzeigen